Health

NX Group Signs Strategic Partnership Agreement with Controlant of Iceland

- Set to Provide Real-time Monitoring Service for Tracking Cargo Location and Strict Temperature Control - TOKYO, June 25, 2024 /PRNewswire/ -- NIPPON EXPRESS HOLDINGS, INC. has signed a strategic partnership agreement withIceland-based Controlant, Inc., a leading provider of real-time monitorin...

2024-06-25 14:00 1443

IBISA raises $3 million to scale parametric insurance solutions, strengthening climate resilience across Asia and Africa.

LUXEMBOURG, June 25, 2024 /PRNewswire/ -- IBISA , a Climate Insurtech company, has closed a$3 million funding round to scale its parametric insurance solutions for weather-related risks inAsia and Africa. The round was led by The Acumen Resilient Agriculture Fund (ARAF) an...

2024-06-25 13:00 1865

Singclean: Unveiled Singfiller® and Singderm® in IMCAS ASIA 2024, Poised for Thailand's Big Launch

BANGKOK, June 25, 2024 /PRNewswire/ -- Singclean, a global player and a leading Chinese manufacturer of high-quality medical aesthetic products, was excited to announce in IMCAS Asia that Singfiller® and Singderm® HA fillers will launch in Thailand this November. Although still not officially cer...

2024-06-25 11:00 2186

Innovent Presents the Results of the First Phase 3 Study of Mazdutide for Weight Management at the ADA's 84th Scientific Sessions

SAN FRANCISCO and SUZHOU, China, June 25, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ...

2024-06-25 08:17 2199

Innovent Announces Mazdutide Demonstrates 80.2% Reduction in Liver Fat Content in Exploratory Analysis of Phase 3 Weight Management GLORY-1 Study at ADA 2024

SAN FRANCISCO and SUZHOU, China, June 25, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ...

2024-06-25 08:00 2358

NABR Commends the IUCN's Decision to Reassess the Status of Long-Tailed Macaques

A Science-Based Approach Will Determine if the Species is Truly 'Endangered' WASHINGTON, June 25, 2024 /PRNewswire/ -- The National Association for Biomedical Research (NABR) commends the Union for the Conservation of Nature (IUCN)'s decision to reassess the 'Endangered' designation of long-taile...

2024-06-25 05:32 1737

Science and Technology Daily: China's Fertile Grounds for Innovation

BEIJING, June 24, 2024 /PRNewswire/ -- On June 24, ten experts received the China International Science and Technology Cooperation Award at the National Science and Technology Award Conference inBeijing.   Science and Technology Daily: China's Fertile Grounds for Innovation They stand as eminen...

2024-06-24 21:41 2252

Bota Bio's Biomanufacturing Technology is Commercialized at NHU with A Successful Strategic Partnership Established

Bota's end-to-end bio-foundry tackles the challenge of transitioning from lab-developed technology to industrial-scale production, and empowers the rapid and efficient translation of cutting-edge biotechnology into tangible commercial value. SAN FRANCISCO, HANGZHOU and XINCHANG, China, June 24, ...

2024-06-24 21:00 1739

iRegene Receives IND approval from U.S. FDA to Start Clinical Trial for Parkinson's Disease

WUHAN, China, June 24, 2024 /PRNewswire/ -- On June 20 (UTC-4), the U.S. Food and Drug Administration (FDA) approved the IND application for NouvNeu001, a cell therapy product from iRegene therapeutics targeting Parkinson's Disease. This marks a significant milestone as NouvNeu001 becomes the wor...

2024-06-24 20:00 1567

TiumBio Presents Promising Clinical Data from Phase 1 of its Hemophilia Treatment Candidate TU7710 at ISTH 2024

* TU7710, long-acting recombinant activated factor VII, demonstrated a 5 to 7 times longer half-lifein a Phase 1 study than that of NovoSeven, a conventional hemophilia treatment for patients who develop inhibitors * TiumBio presented interim Phase 1a clinical data of TU7710 and discussed pot...

2024-06-24 20:00 1785

Wingderm® Shines at IMCAS Asia 2024 with the Innovative Aesthetic Solutions

BEIJING, June 24, 2024 /PRNewswire/ -- From June 21 to 23, IMCAS Asia was held inBangkok, Thailand. Wingderm®, a provider of medical aesthetic devices, has garnered significant attention with its innovative aesthetic solutions.

2024-06-24 12:31 1665

AXA Celebrates Record-Breaking 10 Industry Wins at Bloomberg Businessweek Financial Institutions Awards 2024

HONG KONG, June 24, 2024 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") set a record at the Bloomberg Businessweek Financial Institutions Awards 2024, winning a total of ten prestigious awards. This remarkable achievement includes six Excellence awards and four Outstanding awards, covering vario...

2024-06-24 12:08 1977

Juniper Biologics Expands Distribution Rights for Caris Life Sciences' Molecular Profiling in the Middle East and Africa

SINGAPORE, June 24, 2024 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare and pharmaceuticals company focused on commercialising novel therapies, has been granted distribution rights for Caris Life Sciences (Caris)' solid tumour molecular profiling...

2024-06-24 09:00 1776

Ascentage Pharma Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering of American Depositary Shares

ROCKVILLE, Md. and SUZHOU, China, June 24, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK) announced that it has confidentially submitted a draft registration statement on Form F-1 to the U.S. Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of Amer...

2024-06-24 08:15 3130

Gan & Lee Pharmaceuticals Announces Significant Progress on New Diabetes and Obesity Treatments at the American Diabetes Association's 84th Scientific Sessions

BEIJING and BRIDGEWATER, N.J., June 23, 2024 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) announced the results of the Phase1b/2a clinical study of the Company's independently developed glucagon-like peptide-1 (GLP-1) receptor agonist, GZR18 Injection, in...

2024-06-23 21:09 2972

Sciwind Biosciences to Highlight Positive Results for Injectable Ecnoglutide (Phase 3), Oral Ecnoglutide (Phase 1), and Novel Amylin Analogs at the American Diabetes Association (ADA) 84th Annual Conference

* A Phase 1 study of oral ecnoglutide (1871-LB) showed it to be safe and well tolerated and result in pronounced weight loss (up to -6.76% after 6 weeks of dosing). Improved oral bioavailability enables a 15 to 30 mg daily dose of oral ecnoglutide to match or exceed the plasma exposure of weekl...

2024-06-22 07:00 5130

Pierre Fabre Laboratories receives the Galien International Prize for EBVALLO®, the first allogeneic immunotherapy for patients with a rare cancer

CASTRES, France, June 21, 2024 /PRNewswire/ -- Pierre Fabre Laboratories has been awarded the "Prix Galien International" Prize in the "Best Product for a Rare/Orphan Disease" category for EBVALLO® (tabelecleucel), indicated as monotherapy for the treatment of patients with post-transplant l...

2024-06-21 19:28 2360

Biocytogen Awarded U.S. Patent for RenLite® Common Light Chain Mouse Platform

BEIJING, June 21, 2024 /PRNewswire/ -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) announced United States Patent and Trademark Office (USPTO) patent grant for independently developed RenLite® fully human common light chain mouse platform.

2024-06-21 17:45 8424

ISTH announces launch of new global education initiative in factor XI/XIa inhibition

Leading international society embarks on multi-year initiative to increase clinician awareness of factor XI/XIa inhibition BANGKOK, June 21, 2024 /PRNewswire/ -- The International Society on Thrombosis and Haemostasis (ISTH), the leading worldwide not-for-profit organization dedicated to advanci...

2024-06-21 14:00 2572

ISTH Releases Evidence-Based Clinical Practice Guideline for Hemophilia Treatment

CHAPEL HILL, N.C., June 21, 2024 /PRNewswire/ -- The International Society on Thrombosis and Haemostasis (ISTH), the leading international professional medical-scientific organization dedicated to advancing the understanding, prevention, diagnosis, and treatment of conditions related to thrombosi...

2024-06-21 14:00 1835
1 ... 65666768697071 ... 858